Skip to content
GLP-1 Scorecard
Menu
Site position #25

No BS RX

Published by GLP-1 ScorecardUpdated

Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.

Visit No BS RXWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$179/mo month-to-month (a separate low-dose program is $140)
Tirzepatide
$249/mo month-to-month (a separate low-dose program is $140)
Coverage
Not publicly listed
Brand-name
Not confirmed

Weigh No BS RX against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value92/100
Dose & formulation90/100
Clinical oversight72/100
Labs & monitoring68/100
Fulfillment94/100
Contract terms74/100

Strengths

  • Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
  • "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
  • Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
  • Six programs across four terms are published with no intake and no account
  • A sleep program is priced on the same page, including a diagnostic ring study at $33/mo

What to consider

  • The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
  • The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
  • The Terms name four pharmacies and no operating company
  • State availability is not published, and there is no FDA-approved brand lane

Bottom line — Grade B−

Best for: Anyone who wants to compare every term and every dose level without starting an intake to see a price.

Site position #25 of 542. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest No BS RX — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect No BS RX's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on No BS RX's site. Not medical advice; see our disclosure.

← Back to the scorecard